What’s at Stake for Washington’s Flagship Research Institutions in the Legal Battle Over NIH Funding

The fight now unfolding over the Trump administration’s sudden limit on National Institutes of Health grant funding could have deep financial implications for Washington state’s top research institutions. Those impacted would include the University of Washington, Fred Hutch Cancer Center, Washington State University, PATH, Seattle Children’s, biotech companies and many others. Organizations in the Seattle area alone received $1.13B in NIH funding during the fiscal year ending in the third quarter of 2024, according to CBRE Research.